|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions

News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia


Market Summary
News
IPOs

Company Profiles

Companies
Events

Research Store

Biotech Events
Post an Event

Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Bio-Images Research Ltd. Develops the 'HS Capsule' for Site-Specific Drug Release
5/7/2010 2:49:54 PM
Glasgow, U.K., 6th May 2010 – Bio-Images Research Ltd. has developed a novel capsule system for site-specific delivery of drugs.
The ‘Hydrophilic Sandwich’ (HS) capsule is a ‘capsule within a capsule’, with the formulation of interest in the inner capsule and a layer of gelling, erodible polymer located within the inter-capsule space. With judicious choice of the density of the polymer layer, the time taken for erosion of this layer, and subsequent bursting of the inner capsule and release of the formulation, can be controlled. A clinical study on this novel site-specific delivery device? conducted by Bio-Images using the imaging technique, gamma scintigraphy?has shown that it can be used to effectively target the distal small intestine and could be a useful tool in regional absorption studies.
Bio-Images clinical site staff will be present to discuss this research on the HS capsule with members of the pharmaceutical and biotechnology industries at the 37th Annual Meeting and Exposition of the Controlled Release Society, Portland, Oregon, 10th – 14th July 2010. Dr Fiona McInnes, on behalf of Bio-Images, will deliver a podium presentation entitled “Site-Specific Delivery With The HS Capsule: A Gamma Scintigraphic Study”.
Gamma scintigraphy is a well established non-invasive imaging technique used to assess the in vivo behaviour of novel formulations, and can also be combined with pharmacokinetics. Information from these studies assist in drug development decision and marketing of new formulations or reformulations. Bio-Images has particular expertise in solving concerns with ‘problem’ formulations, such as dose dumping and food effects.
Bio-Images’ clinical research team will be exhibiting at the 2010 Controlled Release Society Annual Meeting at booth #827.
|
|
|
|
|
|
|
|
|
|
|